1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSaving Lives and Livelihoods Program Phase II is sponsored by Tanzania Medicines and Medical Devices Authority (TMDA). Aims to strengthen healthcare delivery and patient safety through enhanced pharmacovigilance practices in Tanzania.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
TMDA | SAVING LIVES AND LIVELIHOODS PROGRAM Regulatory Reliance Pathways for Marketing Authorisation of Human Medicinal Products Ban on the Use of Veterinary Medicinal Products Containing Levamisole as an Active Pharmaceutical Ingredient Ban on the Use of Medicinal Products Containing Levamisole as Active Pharmaceutical Ingredient Ufafanuzi wa Changamoto za Mfumo Mpya wa Pamoja wa Ugomboaji wa Mizigo (TANESW) TMDA Maintains WHO Maturity Level 3 (ML3) Status WHO Maturity Level Three (ML-3) The implementation schedule for Phase 2 of the SLL program is 1 year, from 13th February 2025 to 31st December 2025.
The Saving Lives and Livelihoods (Phase II) program aims to strengthen healthcare delivery and patient safety through enhanced pharmacovigilance practices in Tanzania. The program is funded by the Mastercard Foundation through Africa CDC. This phase builds on the successes of previous initiatives and aligns with the objectives set forth by the Tanzania Medicines and Medical Devices Authority (TMDA).
For more information about the Saving Lives and Livelihoods (Phase II) program, click here...
According to the current listing, eligibility includes: Nonprofits, community organizations, and individuals in Tanzania. Confirm the full requirements in the official notice before applying.
Saving Lives and Livelihoods Program Phase II is funded by Tanzania Medicines and Medical Devices Authority (TMDA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Five NHLBI Catalyze Product Definition RFAs — HL-26-016 through HL-26-020 — carry an October 21, 2026 receipt date, budget caps of $300,000 to $400,000 per year, and roughly 8 new awards annually. The science is not the gate. An Accelerator Partner and a 0.25:1 non-federal cost match are, and both take longer to line up than the nine weeks you have left.
Read articleARPA-H's FASTPASS program targets a public-health blind spot: substandard and contaminated drugs that are only caught after patients are exposed. It funds through-package chemical sensing (TA1 SAMPLE) and the analytics to act on it (TA2 DETECT). The solicitation posts to SAM.gov in mid-August 2026, with a virtual Proposer Workshop on August 24 and registration closing August 20. Here is what FASTPASS funds, why the timing matters, and how to position a cross-disciplinary team.
Read articleARPA-H's new REST program (ARPA-H-SOL-26-159) wants to move sleep diagnosis out of the lab and into the bedroom — and then close the loop with real-time, at-home treatment. It is a 66-month, three-phase Other Transaction effort aimed at a health burden ARPA-H pegs at $400 billion a year. The gating step is deceptively small: a mandatory Solution Summary due August 12, 2026, that decides who ever gets to submit a full proposal. Here is what REST is really asking for, why the two technical areas favor interdisciplinary teams, and how to treat the solution summary as the actual competition.
Read article